Liquid Dosage

Therapeutical Proteins

Protein-based therapeutics are increasingly being developed as new chemical entities in the pharmaceutical and life science industries. Unlike small molecules, which are typically synthesized using chemical processes, most proteins need to be processed in living systems, mostly by recombinant DNA technology. The proteins can then be produced in their functional form (quaternary structure), rather than by microbial biosynthesis (bacteria/yeast), substantially reducing the downstream stages of the process.

The GEA Advantage

As the demand for large-volume products increases, so does the requirement for higher capacity reactors (up to 20,000 L) to realize economies of scale. GEA has responded to the changing needs of biopharmaceutical manufacturers and developed improved technology solutions to optimize both upstream and, with increasing titers, downstream processing, in terms of time and cost efficiency.

Based on its history of innovation and process development, GEA has a thorough working knowledge of therapeutic protein production and has used this competence to design better media and feeding strategies, optimize the fermentation stage and enhance physicochemical conditions during the manufacturing process.

A leading international supplier of integrated process systems, our extensive portfolio of products, technologies and services includes standard and customized fermenters, separators and entire production lines, as well as plant for the production, storage and distribution of clean utilities. Systems for the preparation of media, fluid management, cell cultivation and purification are also part of our global scope of supply.

As a competent manufacturer of complete plant for the life science industries, GEA is a full-service provider of solutions that meet your exact requirements and specifications. From planning, development and installation to qualification and maintenance, our experienced engineers will collaborate with your project team to supply innovative and efficient process solutions for your applications.

GEA 洞察

通过可持续制冷保证面向未来的冷链

优质冷链管理的重要性不可低估。确保易腐食品在食用时安全且高质量是冷链设施运营商的巨大责任。GEA 处于为冷库和配送中心提供安全、可持续制冷技术的前沿,帮助客户减少其设施的能源消耗和碳排放。

Josep Masramón and his daughter stand in front of their GEA batch milking installation.

批量挤奶如何支持现代奶牛养殖业

自动挤奶的最新发展引入了批量挤奶 – 一种在固定挤奶时间将奶牛分组挤奶的奶牛养殖实践,通常每天两次到三次。自动化技术正在帮助奶农克服近期的挑战,平衡奶牛场的奶牛福利、灵活性和可持续性,同时不断优化其成本结构并实现越来越高效的优势。

从稀薄的空气中

在许多国家/地区,获得安全用水和卫生设施体系仍然是一个挑战。由于饮用水不干净以及每天长途跋涉取水而生病,意味着许多儿童无法上学。GEA 通过与汉堡非营利组织 Viva con Agua 合作,使用一些非常神奇的技术帮助为坦桑尼亚的几所学校提供干净的水。

接收 GEA 新闻

订阅 GEA 的新闻,掌握 GEA 的创新信息和故事。

联系我们

我们随时为你提供帮助!你只需提供少量详细信息,我们就能回复你的查询。